400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Cytoskeleton / Gap Junction / Danegaptide
CAS No.: 943134-39-2
Synonyms: GAP-134;ZP 1609
GAP-134, a small modified dipeptide, has been identified as a potent and selective second generation gap junction modifier with oral bioavailability.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00820521 | Healthy Subjects | Phase 1 | Withdrawn | April 2009 | - |
NCT00510029 | Arrhythmia | Phase 1 | Completed | - | United States, Pennsylvania ... more >> Philadelphia, Pennsylvania, United States, 19148 Collapse << |
NCT00543946 | Arrhythmia | Phase 1 | Completed | - | Japan ... more >> Shinagawa-Ku, Tokyo, Japan, 141-0001 Collapse << |
实验方案
技术信息
CAS号 | 943134-39-2 | 储存条件 |
|
|
分子式 | C14H17N3O4 | 运输 | 蓝冰 | |
分子量 | 291.30 | 别名 | GAP-134;ZP 1609 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00820521 | Healthy Subjects | Phase 1 | Withdrawn | April 2009 | - |
NCT00510029 | Arrhythmia | Phase 1 | Completed | - | United States, Pennsylvania ... more >> Philadelphia, Pennsylvania, United States, 19148 Collapse << |
NCT00543946 | Arrhythmia | Phase 1 | Completed | - | Japan ... more >> Shinagawa-Ku, Tokyo, Japan, 141-0001 Collapse << |
NCT00783341 | Healthy Subjects | Phase 1 | Completed | - | United States, Pennsylvania ... more >> Philadelphia, Pennsylvania, United States, 19428 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网